Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy.

Judith Stangl-KremserMichael SunBenedict HoJoseph ThomasJones T NauseefJoseph R OsborneAna MolinaCora N SternbergDavid M NanusNeil H BanderScott Tagawa

Published in: The Prostate (2023)

NLR provides prognostic information in the setting of patients with mCRPC receiving treatment with PSMA-TRT.

Keyphrases

prostate cancer
pet ct
pet imaging
cancer therapy
benign prostatic hyperplasia
stem cells
health information
computed tomography
bone marrow
smoking cessation
positron emission tomography